Eprinomectin B1b is a semi-synthetic analogue of avermectin B1b prepared by oxidation of the 4-hydroxy moiety and reductive amination followed by acetylation. Eprinomectin B1b is the minor component (<10%) of the commercial product for endo- and exo-para
